Back to Events

Praxis Precision Medicines virtual investor event to discuss clinical programs in Developmental and Epileptic Encephalopathies (DEEs)

Praxis Banner
DATE: May 2, 2025
TIME: 10:00 AM EDT
LOCATION: Virtual

About The Event

Join Praxis Precision Medicines for a virtual investor event hosted by company management, who will focus on their DEE clinical programs including:

  • The EMBOLD study evaluating relutrigine for SCN2A and SCN8A DEEs
  • The EMERALD study evaluating relutrigine for broader DEEs
  • The EMBRAVE3 study evaluating elsunersen for SCN2A GoF DEEs

A live question and answer session will follow the formal presentations.